Histologic grade as prognostic indicator for mucoepidermoid carcinoma: A population-level analysis of 2400 patients

Head and Neck

Volumn 36, Issue 2, 2014, Pages 158-163

  Chen, Michelle M ^a   Roman, Sanziana A ^b   Sosa, Julie A ^b   Judson, Benjamin L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

lymph node metastases; mucoepidermoid carcinoma; parotid gland; salivary gland carcinoma; survival

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PAROTID GLAND; PAROTID GLAND CANCER; PAROTIDECTOMY; POPULATION RESEARCH; PRIORITY JOURNAL;

LYMPH NODE METASTASES; MUCOEPIDERMOID CARCINOMA; PAROTID GLAND; SALIVARY GLAND CARCINOMA; SURVIVAL;

AGED; CARCINOMA, MUCOEPIDERMOID; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM GRADING; PAROTID NEOPLASMS; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84892435334     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23256     Document Type: Article

References (25)

1. Ettl T, Schwarz-Furlan S, Gosau M, Reichert TE,. Salivary gland carcinomas. Oral Maxillofac Surg 2012; 16: 267-283.
2. International Academy of Pathology, World Health Organization, International Agency for Research on Cancer. Pathology and genetics of head and neck tumours. Lyon, France: IARC Press; 2005. p 430.
3. Vander Poorten V, Bradley PJ, Takes RP, Rinaldo A, Woolgar JA, Ferlito A,. Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology. Head Neck 2012; 34: 429-440.
4. Schwarz S, Stiegler C, Müller M, et al. Salivary gland mucoepidermoid carcinoma is a clinically, morphologically and genetically heterogeneous entity: a clinicopathological study of 40 cases with emphasis on grading, histological variants and presence of the t(11;19) translocation. Histopathology 2011; 58: 557-570.
5. Seethala RR,. An update on grading of salivary gland carcinomas. Head Neck Pathol 2009; 3: 69-77.
6. Nance MA, Seethala RR, Wang Y, et al. Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer 2008; 113: 2082-2089.
7. McHugh CH, Roberts DB, El-Naggar AK, et al. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer 2012; 118: 3928-3936.
8. Aro K, Leivo I, Mäkitie AA,. Management and outcome of patients with mucoepidermoid carcinoma of major salivary gland origin: a single institution's 30-year experience. Laryngoscope 2008; 118: 258-262.
9. Auclair PL, Goode RK, Ellis GL,. Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases. Cancer 1992; 69: 2021-2030.
10. Ghosh-Laskar S, Murthy V, Wadasadawala T, et al. Mucoepidermoid carcinoma of the parotid gland: factors affecting outcome. Head Neck 2011; 33: 497-503.
11. Bhattacharyya N, Fried MP,. Determinants of survival in parotid gland carcinoma: a population-based study. Am J Otolaryngol 2005; 26: 39-44.
12. Emerick KS, Fabian RL, Deschler DG,. Clinical presentation, management, and outcome of high-grade mucoepidermoid carcinoma of the parotid gland. Otolaryngol Head Neck Surg 2007; 136: 783-787.
13. Bhattacharyya N, Fried MP,. Nodal metastasis in major salivary gland cancer: predictive factors and effects on survival. Arch Otolaryngol Head Neck Surg 2002; 128: 904-908.
14. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program Brochure. Available at: http://seer.cancer.gov/about/factsheets/ SEER-brochure.pdf. Accessed September 13, 2012.
15. Robbins KT, Shaha AR, Medina JE, et al. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 2008; 134: 536-538.
16. Goode RK, Auclair PL, Ellis GL,. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998; 82: 1217-1224.
17. Brandwein MS, Ferlito A, Bradley PJ, Hille JJ, Rinaldo A,. Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcomes. Acta Otolaryngol 2002; 122: 758-764.
18. Batsakis JG, Luna MA,. Histopathologic grading of salivary gland neoplasms: I. Mucoepidermoid carcinomas. Ann Otol Rhinol Laryngol 1990; 99 (10 Pt 1): 835-838.
19. Brandwein MS, Ivanov K, Wallace DI, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 2001; 25: 835-845.
20. National Comprehensive Cancer Network. Head and Neck Cancers, Version 1.2012. Available at: http://www.nccn.org/professionals/physician-gls/pdf/head- and-neck.pdf. Accessed September 28, 2012.
21. Armstrong JG, Harrison LB, Thaler HT, et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 1992; 69: 615-619.
22. Chisholm EJ, Elmiyeh B, Dwivedi RC, et al. Anatomic distribution of cervical lymph node spread in parotid carcinoma. Head Neck 2011; 33: 513-515.
23. Régis De Brito Santos I, Kowalski LP, Cavalcante De Araujo V, Flávia Logullo A, Magrin J,. Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. Arch Otolaryngol Head Neck Surg 2001; 127: 56-60.
24. Kelley DJ, Spiro RH,. Management of the neck in parotid carcinoma. Am J Surg 1996; 172: 695-697.
25. Harlan LC, Hankey BF,. The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies. J Clin Oncol 2003; 21: 2232-2233.